Welcome to LookChem.com Sign In|Join Free
  • or
1-(3,5-difluoropyridin-2-yl)ethanone is a chemical compound that features a fusion of the fluoropyridine and ethanone functional groups. It is distinguished by the presence of two fluorine atoms at the 3 and 5 positions on the pyridine ring, which is connected to an ethanone group via a single bond. 1-(3,5-difluoropyridin-2-yl)ethanone's properties are likely influenced by the electronegative fluorine atoms and the polar nature of the ethanone group, suggesting potential applications in chemical synthesis and the development of pharmaceuticals and materials. However, further research is required to determine its exact uses and reactivity.

1075756-90-9

Post Buying Request

1075756-90-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1075756-90-9 Usage

Uses

Used in Chemical Synthesis:
1-(3,5-difluoropyridin-2-yl)ethanone is used as an intermediate in the synthesis of various complex organic molecules, leveraging its unique structural features and reactivity.
Used in Pharmaceutical Development:
1-(3,5-difluoropyridin-2-yl)ethanone is used as a building block in the design and synthesis of new pharmaceutical compounds, potentially contributing to the development of novel drugs with improved therapeutic properties.
Used in Material Science:
1-(3,5-difluoropyridin-2-yl)ethanone is used as a component in the creation of advanced materials, such as polymers and composites, where its fluorinated and polar characteristics may enhance specific material properties.

Check Digit Verification of cas no

The CAS Registry Mumber 1075756-90-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,5,7,5 and 6 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1075756-90:
(9*1)+(8*0)+(7*7)+(6*5)+(5*7)+(4*5)+(3*6)+(2*9)+(1*0)=179
179 % 10 = 9
So 1075756-90-9 is a valid CAS Registry Number.

1075756-90-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(3,5-Difluoropyridin-2-yl)ethanone

1.2 Other means of identification

Product number -
Other names 1-(3,5-difluoropyridin-2-yl)ethanone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1075756-90-9 SDS

1075756-90-9Relevant academic research and scientific papers

2-(IMIDAZ0LYLAMIN0)-PYRIDINE DERIVATIVES AND THEIR USE AS JAK KINASE INHIBITORS

-

Page/Page column 61, (2010/04/03)

The present inv ention relates to compounds of Formula (I): or a pharmaceutically acceptable salt thereof, wherein Ring A is 5- or 6-membered heteroaryl, wherein said 5- or 6-membered heteroaryl is optionally substituted on carbon with one or more R6

HETEROCYCLIC JAK KINASE INHIBITORS

-

Page/Page column 82, (2010/04/27)

The present invention relates to compounds of Formula (I) and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds provide a treatment for myeloproliferative disorders and cancer

TRICYCLIC 2,4-DIAMIN0-L,3,5-TRIAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF CANCER AND MYELOPROLIFERATIVE DISORDERS

-

Page/Page column 80-81, (2010/01/07)

The present invention relates to compounds of Formula (I): (I) and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds provide a treatment for myeloproliferative disorders and cancer.

PYRAZOLYL-AMINO-SUBSTITUTED PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CANCER

-

Page/Page column 97, (2008/12/08)

The present invention relates to compounds of Formula (I) and to their pharmaceutical compositions, and to their methods of use. These compounds provide a treatment for myeloproliferative disorders and cancer.

CHEMICAL COMPOUNDS

-

Page/Page column 57, (2010/11/25)

This invention relates to novel compounds having the formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.

GUANIDINE COMPOUNDS, AND USE THEREOF AS BINDING PARTNERS FOR 5-HT5 RECEPTORS

-

Page/Page column 96; 97, (2010/02/13)

The invention relates to guanidine compounds of general formula (I), corresponding enantiomeric, diastereomeric, and/or tautomeric forms thereof, and pharmaceutically acceptable salts thereof. The invention further relates to the use of guanidine compounds as binding partners for 5-HT5 receptors in order to treat diseases modulated by 5-HT5 receptor activity, especially treat neurodegenerative and neuropsychiatric disorders and the signs, symptoms, and malfunctions associated therewith.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1075756-90-9